Illumina Inc (ILMN)vsThermo Fisher Scientific Inc (TMO)
ILMN
Illumina Inc
$194.82
+0.95%
HEALTHCARE · Cap: $28.24B
TMO
Thermo Fisher Scientific Inc
$576.46
+0.02%
HEALTHCARE · Cap: $194.53B
Smart Verdict
WallStSmart Research — data-driven comparison
Thermo Fisher Scientific Inc generates 929% more annual revenue ($45.20B vs $4.39B). ILMN leads profitability with a 19.4% profit margin vs 15.1%. TMO appears more attractively valued with a PEG of 1.73. TMO earns a higher WallStSmart Score of 59/100 (C).
ILMN
Buy54
out of 100
Grade: C-
TMO
Buy59
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+57.7%
Fair Value
$274.93
Current Price
$194.82
$80.11 discount
Margin of Safety
-72.9%
Fair Value
$333.36
Current Price
$576.46
$243.10 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 32 in profit
Large-cap with strong market position
Generating 1.7B in free cash flow
Areas to Watch
Premium valuation, high expectations priced in
Trading at 11.1x book value
4.8% revenue growth
Grey zone — moderate risk
Expensive relative to growth rate
Moderate valuation
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : ILMN
The strongest argument for ILMN centers on Return on Equity. Profitability is solid with margins at 19.4% and operating margin at 18.3%.
Bull Case : TMO
The strongest argument for TMO centers on Market Cap, Free Cash Flow. Profitability is solid with margins at 15.1% and operating margin at 17.9%.
Bear Case : ILMN
The primary concerns for ILMN are P/E Ratio, Price/Book, Revenue Growth.
Bear Case : TMO
The primary concerns for TMO are PEG Ratio, P/E Ratio, Piotroski F-Score.
Key Dynamics to Monitor
ILMN profiles as a value stock while TMO is a mature play — different risk/reward profiles.
ILMN carries more volatility with a beta of 1.47 — expect wider price swings.
TMO is growing revenue faster at 6.2% — sustainability is the question.
TMO generates stronger free cash flow (1.7B), providing more financial flexibility.
Bottom Line
TMO scores higher overall (59/100 vs 54/100), backed by strong 15.1% margins. ILMN offers better value entry with a 57.7% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Illumina Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California.
Visit Website →Thermo Fisher Scientific Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry (including in the biotechnology and pharmaceutical sectors). Based in Waltham, Massachusetts, Thermo Fisher was created in 2006 by the merger of Thermo Electron and Fisher Scientific, to form a company with US$ 9 billion in combined revenues.
Visit Website →Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?